DEMANT Demant A/S
319.20DKK+1.66%Mkt Cap: 9.81B $P/E: 27.80Today
Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hea…
Industry Peers
Medical Devices$169.83BUSDP/E 31.6
$110.49BUSDP/E 21.2
$105.65BUSDP/E 28.5
$61.74BUSDP/E 17.2
$49.03BUSDP/E 50.7
$46.06BUSDP/E 19.2
$32.21BUSDP/E 33.7
$29.24BUSDP/E 14.8
$23.38BUSDP/E 18.5
$22.58BUSDP/E 18.5
$20.33BUSDP/E 25.5
$17.06BUSDP/E 27.9
$16.84BUSDP/E 21.4
$12.51BUSDP/E 77.8
$12.18BUSD
$11.06BUSDP/E 18.0
$10.15BUSDP/E 19.3
$9.88BUSDP/E 45.0
$9.66BUSD
$9.64BUSD
| Headline | Source | Time |
|---|---|---|
Older | ||
Bernstein unveils top European medtech stock picks to buy for H2 Investing.com -- European medtech has had another bruising year, with only Demant and Sonova outperforming the Stoxx 600 in 2026 as the sector’s once-premium valuation continues to de-rate. | ||
Demant AS (WILLF) (Q2 2026) Earnings Call Highlights: Strong H1 Growth Fueled by Oticon Zeal ... Demant AS (WILLF) reports 15% revenue growth in H1 2026, driven by successful product launches and strategic acquisitions, while raising its full-year guidance. | ||